Current status and perspective on molecular targets and therapeutic intervention strategy in hepatic ischemia- reperfusion injury
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hepatic ischemia‒reperfusion injury (HIRI) is a common and inevitable complication of hepatic trauma, liver resection, or liver transplantation. It contributes to postoperative organ failure or tissue rejection, eventually affecting patient prognosis and overall survival. The pathological mechanism of HIRI is highly complex and has not yet been fully elucidated. The proposed underlying mechanisms include mitochondrial damage, oxidative stress imbalance, abnormal cell death, immune cell hyperactivation, intracellular inflammatory disorders and other complex events. In addition to serious clinical limitations, available antagonistic drugs and specific treatment regimens are still lacking. Therefore, there is an urgent need to not only clarify the exact etiology of HIRI but also reveal the possible reactions and bottlenecks of existing drugs, helping to reduce morbidity and shorten hospitalizations. We analyzed the possible underlying mechanism of HIRI, discussed various outcomes among different animal models and explored neglected potential therapeutic strategies for HIRI treatment. By thoroughly reviewing and analyzing the literature on HIRI, we gained a comprehensive understanding of the current research status in related fields and identified valuable references for future clinical and scientific investigations.
Abstract
Hepatic ischemia‒reperfusion injury (HIRI) is a common and inevitable complication of hepatic trauma, liver resection, or liver transplantation. It contributes to postoperative organ failure or tissue rejection, eventually affecting patient prognosis and overall survival. The pathological mechanism of HIRI is highly complex and has not yet been fully elucidated. The proposed underlying mechanisms include mitochondrial damage, oxidative stress imbalance, abnormal cell death, immune cell hyperactivation, intracellular inflammatory disorders and other complex events. In addition to serious clinical limitations, available antagonistic drugs and specific treatment regimens are still lacking. Therefore, there is an urgent need to not only clarify the exact etiology of HIRI but also reveal the possible reactions and bottlenecks of existing drugs, helping to reduce morbidity and shorten hospitalizations. We analyzed the possible underlying mechanism of HIRI, discussed various outcomes among different animal models and explored neglected potential therapeutic strategies for HIRI treatment. By thoroughly reviewing and analyzing the literature on HIRI, we gained a comprehensive understanding of the current research status in related fields and identified valuable references for future clinical and scientific investigations.
참고문헌 (155)
- Ye L, "Effect of hepatic macrophage polarization and apoptosis on liver ischemia and reperfusion injury during liver transplantation", Front Immunol, 11, pp.1193~ (2020)
- Devarbhavi H, "Global burden of liver disease : 2023 update", J Hepatol, 79, pp.516~537 (2023)
- Zhou J, "Nacetylgalactosaminyltransferase-4 protects against hepatic ischemia", reperfusion injury by blocking apoptosis signalregulating kinase 1 N-terminal dimerization, 2022, pp.75, 1446~1460
- Yuan D, "Blue light reduces organ injury from ischemia and reperfusion", Proc Natl Acad Sci U S A, 113, pp.5239~5244 (2016)
- Peralta C, "Hepatic ischemia and reperfusion injury : effects on the liver sinusoidal milieu", J Hepatol, 59, pp.1094~1106 (2013)
- Bavarsad K, "Protective effects of curcumin against ischemiareperfusion injury in the liver", Pharmacol Res, 141, pp.53~62 (2019)
- Pantazi E, "Advances in treatment strategies for ischemia reperfusion injury", Expert Opin Pharmacother, 17, pp.169~179 (2016)
- Jaeschke H, "Apoptosis versus oncotic necrosis in hepatic ischemia", reperfusion injury, 2003, pp.125, 1246~1257
- Peralta C, "Hepatic ischemia and reperfusion injury : effects on the liver sinusoidal milieu", J Hepatol, 59, pp.1094~1106 (2013)
- Xie Y, "Ferroptosis : process and function", Cell Death Differ, 23, pp.369~379 (2016)
- Tang SP, "Reactive oxygen species induce fatty liver and ischemia-reperfusion injury by promoting inflammation and cell death", Front Immunol, 13, pp.870239~ (2022)
- Liu H, "New insights in mechanisms and therapeutics for short-and long-term impacts of hepatic ischemia reperfusion injury post liver transplantation", Int J Mol Sci, 22, pp.8210~ (2021)
- Vartak R, "Respiratory supercomplexes : structure, function and assembly", Protein Cell, 4, pp.582~590 (2013)
- Schusdziarra C, "Methylationcontrolled J-protein MCJ acts in the import of proteins into human mitochondria", Hum Mol Genet, 22, pp.1348~1357 (2013)
- Goikoetxea-Usandizaga N, "Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals", Hepatology, 75, pp.550~566 (2022)
- Teixeira da Silva R, "PEG35 as a preconditioning agent against hypoxia", reoxygenation injury, 2022, pp.23, 1156~
- Shang L, "SS-31Protects liver from ischemia-reperfusion injury via modulating macrophage polarization", Oxid Med Cell Longev, 2021, pp.6662156~ (2021)
- Zeng H, "Copper deficiency decreases complex IV but not complex I, II, III, or V in the mitochondrial respiratory chain in rat heart", J Nutr, 137, pp.14~18 (2007)
- Zhuang R, "Virus-mimicking liposomal system based on dendritic lipopeptides for efficient prevention ischemia", reperfusion injury in the mouse liver, 2021, pp.10, 215~222
- Frye RA, "Characterization of five human cDNAs with homology to the yeast SIR2 gene : Sir2-like proteins(sirtuins)metabolize NAD and may have protein ADP-ribosyltransferase activity", Biochem Biophys Res Commun, 260, pp.273~279 (1999)
- He S, "NAD+ameliorates endotoxin-induced acute kidney injury in a sirtuin1-dependent manner via GSK-3β", Nrf2 signalling pathway, 2022, pp.26, 1979~1993
- Teodoro JS, "Indirubin and NAD+ prevent mitochondrial ischaemia", reperfusion damage in fatty livers, 2018, pp.48, e12932~
- Schlegel A, "Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantation", EBioMedicine, 60, pp.103014~ (2020)
- Lin J, "Mitochondrial dynamics and mitophagy in cardiometabolic disease", Front Cardiovasc Med, 9, pp.917135~ (2022)
- Du YD, "N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation", Cell Death Dis, 12, pp.442~ (2021)
- Huang J, "Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury", Cell Death Differ, 28, pp.1174~1192 (2021)
- Sun X, "A negative feedback regulation of MTORC1 activity by the lysosomal Ca2+ channel MCOLN1(mucolipin 1)using a CALM(calmodulin)-dependent mechanism", Autophagy, 14, pp.38~52 (2018)
- Hanna RA, "Calcium-bound structure of calpain and its mechanism of inhibition by calpastatin", Nature, 456, pp.409~412 (2008)
- Flores-Toro J, "Critical roles of calpastatin in ischemia", reperfusion injury in aged livers, 2021, pp.10, 1863~
- Kong WN, "Augmenter of liver regeneration-mediated mitophagy protects against hepatic ischemia", reperfusion injury, 2022, pp.22, 130~143
- Xu M, "DJ-1 deficiency in hepatocytes improves liver ischemia-reperfusion injury by enhancing mitophagy", Cell Mol Gastroenterol Hepatol, 12, pp.567~584 (2021)
- An W, "Effect of metformin on myocardial injury induced by hepatic ischemia-reperfusion in rats", Front Pharmacol, 13, pp.822743~ (2022)
- Zhang X, "Antioxidant and C5a-blocking strategy for hepatic ischemiareperfusion injury repair", J Nanobiotechnology, 19, pp.107~ (2021)
- Zhang YP, "New progress in understanding roles of nitric oxide during hepatic ischemia-reperfusion injury", World J Hepatol, 14, pp.504~515 (2022)
- Ferreira-Silva M, "Quercetin liposomal nanoformulation for ischemia and reperfusion injury treatment", Pharmaceutics, 14, pp.104~ (2022)
- Hide D, "Ischemia", reperfusion injury in the aged liver : The importance of the sinusoidal endothelium in developing therapeutic strategies for the elderly, 2020, pp.75, 268~277
- Wu J, "Ferulic acid ameliorates hepatic inflammation and fibrotic liver injury by inhibiting PTP1B activity and subsequent promoting AMPK phosphorylation", Front Pharmacol, 12, pp.754976~ (2021)
- Anavi S, "iNOS as a metabolic enzyme under stress conditions", Free Radic Biol Med, 146, pp.16~35 (2020)
- Mu J, "Protective effect of platinum nano-antioxidant and nitric oxide against hepatic ischemia-reperfusion injury", Nat Commun, 13, pp.2513~ (2022)
- Shen Y, "Myricitrin pretreatment ameliorates mouse liver ischemia reperfusion injury", Int Immunopharmacol, 89, pp.107005~ (2020)
- Ma Q, "Role of nrf2 in oxidative stress and toxicity", Annu Rev Pharmacol Toxicol, 53, pp.401~426 (2013)
- Li Z, "Protective effects of fisetin on hepatic ischemia-reperfusion injury through alleviation of apoptosis and oxidative stress", Arch Med Res, 52, pp.163~173 (2021)
- Yi Z, "Immune-responsive gene 1", itaconate activates nuclear factor erythroid 2-related factor 2 in hepatocytes to protect against liver ischemia-reperfusion injury, 2020, pp.72, 1394~1411
- Yu Q, "Veratric acid alleviates liver ischemia", reperfusion injury by activating the Nrf2 signaling pathway, 2021, pp.101, 108294~
- Trocha M, "Sitagliptin modulates oxidative, nitrative and halogenative stress and inflammatory response in rat model of hepatic ischemia-reperfusion", Antioxidants(Basel), 10, pp.1168~ (2021)
- Mao Y, "p21-activated kinase 4 inhibition protects against liver ischemia", reperfusion injury : Role of nuclear factor erythroid 2-related factor 2 phosphorylation, 2022, pp.76, 345~356
- Yuan B, "Gastrodin pretreatment protects liver against ischemia-reperfusion injury via activation of the Nrf2", HO-1 pathway, 2020, pp.48, 1159~1178
- Chen Y, "Kaempferol from penthorum chinense pursh attenuates hepatic ischemia", reperfusion injury by suppressing oxidative stress and inflammation through activation of the Nrf2, Front Pharmacol, pp.2022, 13[DOI]
- Tong G, "FGF18alleviates hepatic ischemia-reperfusion injury via the USP16-mediated KEAP1", Nrf2 signaling pathway in male mice, 2023, pp.14, 6107~
- Feng R, "Nrf2 activation drive macrophages polarization and cancer cell epithelial-mesenchymal transition during interaction", Cell Commun Signal, 16, pp.54~ (2018)
- Kim TH, "NRF2 blockade suppresses colon tumor angiogenesis by inhibiting hypoxia-induced activation of HIF-1α", Cancer Res, 71, pp.2260~2275 (2011)
- Zhang X, "Hypoxiainducible factor-1alpha protects the liver against ischemiareperfusion injury by regulating the A2B adenosine receptor", Bioengineered, 12, pp.3737~3752 (2021)
- Dery KJ, "Alternative splicing of CEACAM1 by hypoxia-inducible factor-1α enhances tolerance to hepatic ischemia in mice and humans", Sci Transl Med, 15, pp.eadf2059~ (2023)
- Wang Q, "Role of XBP1 in regulating the progression of non-alcoholic steatohepatitis", J Hepatol, 77, pp.312~325 (2022)
- Li K, "Chlorogenic acid alleviates hepatic ischemia-reperfusion injury by inhibiting oxidative stress, inflammation, and mitochondria-mediated apoptosis in vivo and in vitro", Inflammation, 46, pp.1061~1076 (2023)
- Saleh H, "Chitosan protects liver against ischemia-reperfusion injury via regulating Bcl-2", Bax, TNF-αand TGF-β expression, 2020, pp.164, 1565~1574
- Wang YL, "Hepatoprotective effects of sevoflurane against hepatic ischemia-reperfusion injury by regulating microRNA-124-3p-mediated TRAF3", CREB axis, 2022, pp.8, 105~
- Hu HH, "New insights into TGF-β", Smad signaling in tissue fibrosis, 2018, pp.292, 76~83
- Yang Y, "Ghrelin ameliorates transformation of hepatic ischemia-reperfusion injury to liver fibrosis by blocking Smad and ERK signalling pathways, and promoting anti-inflammation and anti-oxidation effects", Transpl Immunol, 73, pp.101597~ (2022)
- Pan WM, "miR-210 Participates in hepatic ischemia reperfusion injury by forming a negative feedback loop with SMAD4", Hepatology, 72, pp.2134~2148 (2020)
- Zheng X, "hsa-miR-34a-5p Ameliorates hepatic ischemia", reperfusion injury via targeting HNF4α, 2022, pp.33, 596~605
- Zhu S, "Hippo(YAP)-autophagy axis protects against hepatic ischemiareperfusion injury through JNK signaling", Chin Med J(Engl), 137, pp.657~668 (2024)
- Guo WZ, "Sixtransmembrane epithelial antigen of the prostate 3 deficiency in hepatocytes protects the liver against ischemia-reperfusion injury by suppressing transforming growth factor-β-activated kinase 1", Hepatology, 71, pp.1037~1054 (2020)
- Chen SY, "Tripartite motif-containing 27 attenuates liver ischemia", reperfusion injury by suppressing transforming growth factor β-activated kinase 1(TAK1)by TAK1 binding protein 2, Hepatology, pp.2021, 73[DOI]
- Zhang JK, "Regulator of G-protein signaling 14 protects the liver from ischemia-reperfusion injury by suppressing TGF-β-activated kinase 1 activation", Hepatology, 75, pp.338~352 (2022)
- Ding MJ, "E3 ubiquitin ligase ring finger protein 5 protects against hepatic ischemia reperfusion injury by mediating phosphoglycerate mutase family member 5 ubiquitination", Hepatology, 76, pp.94~111 (2022)
- Zhou J, "Nacetylgalactosaminyltransferase-4 protects against hepatic ischemia", reperfusion injury by blocking apoptosis signalregulating kinase 1 N-terminal dimerization, 2022, pp.75, 1446~1460
- Chen X, "β-Arrestin-2 attenuates hepatic ischemia-reperfusion injury by activating PI3K", Akt signaling, 2020, pp.13, 2251~2263
- Tang D, "Maresin 1 protects the liver against ischemia", reperfusion injury via the ALXR, Mol Med, pp.2021, 27[DOI]
- Li Y, "MicroRNA-142-3p attenuates hepatic ischemia", reperfusion injury via targeting of myristoylated alanine-rich C-kinase substrate, 2020, pp.156, 104783~
- Wang M, "Methyl eugenol attenuates liver ischemia reperfusion injury via activating PI3K", Akt signaling, 2021, pp.99, 108023~
- Ding J, "Cordycepin Protects against Hepatic Ischemia", Reperfusion Injury via Inhibiting MAPK, Mediators Inflamm, pp.2022, 2022[DOI]
- Kim HJ, "Carbon monoxide protects against hepatic ischemia", reperfusion injury by modulating the miR-34a, Biochim Biophys Acta, pp.2015, 1852[DOI]
- Samuvel DJ, "LP342, a novel histone deacetylase inhibitor, decreases nitro-oxidative stress, mitochondrial dysfunction and hepatic ischaemia", reperfusion injury in mice, 2023, pp.2, rqad013~
- Luo J, "PIAS1 Alleviates hepatic ischemia-reperfusion injury in mice through a mechanism involving NFATc1 SUMOylation", Dis Markers, 2022, pp.4988539~ (2022)
- Burdette BE, "Gasdermin D in pyroptosis", Acta Pharm Sin B, 11, pp.2768~2782 (2021)
- Kadono K, "Myeloid Ikaros-SIRT1 signaling axis regulates hepatic inflammation and pyroptosis in ischemia-stressed mouse and human liver", J Hepatol, 76, pp.896~909 (2022)
- Szabo G, "Inflammasome activation and function in liver disease", Nat Rev Gastroenterol Hepatol, 12, pp.387~400 (2015)
- Wu Y, "Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K", AKT, J Cell Mol Med, pp.2021, 25[DOI]
- Kolachala VL, "Ischemia reperfusion injury induces pyroptosis and mediates injury in steatotic liver thorough Caspase 1 activation", Apoptosis, 26, pp.361~370 (2021)
- Yamada N, "Iron overload as a risk factor for hepatic ischemiareperfusion injury in liver transplantation : Potential role of ferroptosis", Am J Transplant, 20, pp.1606~1618 (2020)
- Li C, "Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis", Cell Death Dis, 14, pp.810~ (2023)
- Zhang Y, "Radix Rehmanniae Praeparata aqueous extract improves hepatic ischemia", reperfusion injury by restoring intracellular iron homeostasis, 2023, pp.21, 1~17
- Roh JS, "Damage-associated molecular patterns in inflammatory diseases", Immune Netw, 18, pp.e27~ (2018)
- Du Y, "The dietary supplement γ-oryzanol attenuates hepatic ischemia reperfusion injury via inhibiting endoplasmic reticulum stress and HMGB1", NLRP3 inflammasome, 2021, pp.2021, 4628050~
- Ma T, "Protective effect of pinocembrin from Penthorum chinense Pursh on hepatic ischemia reperfusion injury via regulating HMGB1", TLR4 signal pathway, 2023, pp.37, 181~194
- Le Bastard Q, "The effects of inulin on gut microbial composition : a systematic review of evidence from human studies", Eur J Clin Microbiol Infect Dis, 39, pp.403~413 (2020)
- Kawasoe J, "Propionic acid, induced in gut by an inulin diet, suppresses inflammation and ameliorates liver ischemia and reperfusion injury in mice", Front Immunol, 13, pp.862503~ (2022)
- Kawasoe J, "The lectin-like domain of thrombomodulin is a drug candidate for both prophylaxis and treatment of liver ischemia and reperfusion injury in mice", Am J Transplant, 21, pp.540~551 (2021)
- Coughlin SR, "Thrombin signalling and protease-activated receptors", Nature, 407, pp.258~264 (2000)
- Noguchi D, "The impact of dabigatran treatment on sinusoidal protection against hepatic ischemia", reperfusion injury in mice, 2021, pp.27, 363~384
- Sosa RA, "Disulfide high-mobility group box 1 drives ischemiareperfusion injury in human liver transplantation", Hepatology, 73, pp.1158~1175 (2021)
- Rao J, "Nogo-B is a key mediator of hepatic ischemia and reperfusion injury", Redox Biol, 37, pp.101745~ (2020)
- Bai C, "Ac2‑26 alleviates hepatic ischemia‑reperfusion injury based on inhibiting the positive feedback loop of HMGB1", TLR4, neutrophils, pp.Exp Ther Med, 2022[DOI]
- Gendy AM, "Berberine-loaded nanostructured lipid carriers mitigate warm hepatic ischemia", reperfusion-induced lesion through modulation of HMGB1, NF-κB signaling and autophagy, pp.Biomed Pharmacother, 2022[DOI]
- Liang C, "Silencing lncRNA KCNQ1OT1 reduced hepatic ischemia reperfusion injury-induced pyroptosis by regulating miR-142a-3p", HMGB1axis, 2023, pp.478, 1293~1305
- Jia K, "Acteoside ameliorates hepatic ischemia-reperfusion injury via reversing the senescent fate of liver sinusoidal endothelial cells and restoring compromised sinusoidal networks", Int J Biol Sci, 19, pp.4967~4988 (2023)
- Terry AQ, "Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation", Am J Transplant, 23, pp.1858~1871 (2023)
- Barbier L, "Endogenous interleukin-33 acts as an alarmin in liver ischemia-reperfusion and is associated with injury after human liver transplantation", Front Immunol, 12, pp.744927~ (2021)
- Zhang HM, "ILC2s expanded by exogenous IL-33 regulate CD45+CD11b+F4", 80high macrophage polarization to alleviate hepatic ischemia-reperfusion injury, 2022, pp.13, 869365~
- Li S, "Modulation of type I interferon signaling by natural products in the treatment of immunerelated diseases", Chin J Nat Med, 21, pp.3~18 (2023)
- Li Y, "Chuanxiong Rhizoma extracts prevent cholestatic liver injury by targeting H3K9ac-mediated and cholangiocyte-derived secretory protein PAI-1 and FN", Chin J Nat Med, 21, pp.694~709 (2023)
- Wang Z, "Activated AXL protects against hepatic ischemia-reperfusion injury by upregulating SOCS-1 expression", Transplantation, 106, pp.1351~1364 (2022)
- Morsy MA, "Protective mechanisms of telmisartan against hepatic ischemia", reperfusion injury in rats may involve PPARγ-induced TLR4, Biomed Pharmacother, pp.2022, 145[DOI]
- Zhou W, "Hypothermic oxygenated perfusion inhibits HECTD3-mediated TRAF3 polyubiquitination to alleviate DCD liver ischemiareperfusion injury", Cell Death Dis, 12, pp.211~ (2021)
- Gendy A, "Morin alleviates hepatic ischemia", reperfusion-induced mischief : In vivo and in silico contribution of Nrf2, TLR4, and NLRP3, 2021, pp.138, 111539~
- Liu Y, "Salidroside alleviates hepatic ischemia-reperfusion injury during liver transplant in rat through regulating TLR-4", NF-κB, Sci Rep, pp.2022, 12[DOI]
- Yang X, "The protective effects of dietary Clostridium butyricum supplementation on hepatic ischemia reperfusion injury in rats", Acta Cir Bras, 37, pp.e370904~ (2022)
- Liu H, "Antibiotic pretreatment attenuates liver ischemia-reperfusion injury by Farnesoid X receptor activation", Cell Death Dis, 13, pp.484~ (2022)
- Schmitz SM, "Inhaled argon impedes hepatic regeneration after ischemia", reperfusion injury in rats, 2020, pp.21, 5457~
- Xue Z, "PACAP neuropeptide promotes hepatocellular protection via CREB-KLF4 dependent autophagy in mouse liver ischemia reperfusion injury", Theranostics, 10, pp.4453~4465 (2020)
- Shi G, "Hepatic interferon regulatory factor 8 expression mediates liver ischemia", reperfusion injury in mice, 2021, pp.192, 114728~
- Krzystek-Korpacka M, "Modulation of prostanoids profile and counter-regulation of SDF-1α", CXCR4and VIP, Int J Mol Sci, pp.2021, 22[DOI]
- Chen H, "The role of MLKL in hepatic ischemia-reperfusion injury of alcoholic steatotic livers", Int J Biol Sci, 18, pp.1096~1106 (2022)
- Qiang X, "Human dermcidin protects mice against hepatic ischemia-reperfusion-induced local and remote inflammatory injury", Front Immunol, 12, pp.821154~ (2022)
- Yin E, "Anti-CD321 antibody immunotherapy protects liver against ischemia and reperfusion-induced injury", Sci Rep, 11, pp.6312~ (2021)
- Ni X, "Carabin deficiency aggravates hepatic ischemia-reperfusion injury through promoting neutrophil trafficking via ras and calcineurin signaling", Front Immunol, 13, pp.773291~ (2022)
- Stephan A, "The NET, the trap and the pathogen : neutrophil extracellular traps in cutaneous immunity", Exp Dermatol, 24, pp.161~166 (2015)
- Guo J, "Histidine-rich glycoprotein alleviates liver ischemia", reperfusion injury in mice with nonalcoholic steatohepatitis, 2021, pp.27, 840~853
- Wang Y, "Resveratrol improves hepatic ischemia-reperfusion injury by inhibiting neutrophils via the ERK signaling pathway", Biomed Pharmacother, 160, pp.114358~ (2023)
- Yazdani HO, "Exercise training decreases hepatic injury and metastases through changes in immune response to liver ischemia", reperfusion in mice, 2021, pp.73, 2494~2509
- Wang H, "Macrophage polarization and liver ischemia-reperfusion injury", Int J Med Sci, 18, pp.1104~1113 (2021)
- Long Y, "Prevention of hepatic ischemia-reperfusion injury by carbohydratederived nanoantioxidants", Nano Lett, 20, pp.6510~6519 (2020)
- Rao J, "Macrophage nuclear factor erythroid 2-related factor 2 deficiency promotes innate immune activation by tissue inhibitor of metalloproteinase 3-mediated RhoA", ROCK pathway in the ischemic liver, 2022, pp.75, 1429~1445
- Liang W, "Sulforaphane exerts beneficial immunomodulatory effects on liver tissue via a Nrf2 pathway-related mechanism in a murine model of hemorrhagic shock and resuscitation", Front Immunol, 13, pp.822895~ (2022)
- Wang YY, "Maslinic acid protects against lipopolysaccharide", d-galactosamine-induced acute liver injury in mice, 2018, pp.119, 49~53
- Ishikawa H, "STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling", Nature, 455, pp.674~678 (2008)
- Zhong W, "Aging aggravated liver ischemia and reperfusion injury by promoting STING-mediated NLRP3 activation in macrophages", Aging Cell, 19, pp.e13186~ (2020)
- Wu XY, "STING Induces liver ischemia-reperfusion injury by promoting calciumdependent caspase 1-GSDMD processing in macrophages", Oxid Med Cell Longev, 2022, pp.8123157~ (2022)
- Nakamoto S, "Lymphangiogenesis and accumulation of reparative macrophages contribute to liver repair after hepatic ischemiareperfusion injury", Angiogenesis, 23, pp.395~410 (2020)
- Wang L, "Resolving the graft ischemia-reperfusion injury during liver transplantation at the single cell resolution", Cell Death Dis, 12, pp.589~ (2021)
- Yang X, "Single-cell profiling reveals distinct immune phenotypes that contribute to ischaemia-reperfusion injury after steatotic liver transplantation", Cell Prolif, 54, pp.e13116~ (2021)
- Sheng M, "CD47-mediated Hedgehog", SMO, Hepatology, pp.2021, 74[DOI]
- Yu J, "Hepatocyte TLR4 triggers inter-hepatocyte Jagged1", Notch signaling to determine NASH-induced fibrosis, 2021, pp.13, eabe1692~
- Jin Y, "Jagged1-mediated myeloid Notch1 signaling activates HSF1", Snail and controls NLRP3 inflammasome activation in liver inflammatory injury, 2020, pp.17, 1245~1256
- Li SL, "Liraglutide attenuates hepatic ischemia-reperfusion injury by modulating macrophage polarization", Front Immunol, 13, pp.869050~ (2022)
- Huang Z, "Inhibition of miR-450b-5p ameliorates hepatic ischemia", reperfusion injury via targeting CRYAB, 2020, pp.11, 455~
- Zhou H, "TGR5", Cathepsin E signaling regulates macrophage innate immune activation in liver ischemia and reperfusion injury, 2021, pp.21, 1453~1464
- Zito G, "Human amnion-derived mesenchymal stromal", stem cells preconditioning inhibits inflammation and apoptosis of immune and parenchymal cells in an in vitro model of liver ischemia, Cells, pp.2022, 11[DOI]
- Dery KJ, "Alternative splicing of CEACAM1 by hypoxia-inducible factor-1α enhances tolerance to hepatic ischemia in mice and humans", Sci Transl Med, 15, pp.eadf2059~ (2023)
- Kojima H, "T Cell CEACAM1-TIM-3 crosstalk alleviates liver transplant injury in mice and humans", Gastroenterology, 165, pp.1233~1248 (2023)
- Terry AQ, "Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation", Am J Transplant, 23, pp.1858~1871 (2023)
- Zhang L, "Effect of intraoperative dexmedetomidine on hepatic ischemia-reperfusion injury in pediatric living-related liver transplantation : A propensity score matching analysis", Front Surg, 9, pp.939223~ (2022)
- Zhang L, "Intraoperative lowdose dexmedetomidine administration associated with reduced hepatic ischemia-reperfusion injury in pediatric deceased liver transplantation : A retrospective cohort study", Ann Transplant, 26, pp.e933354~ (2021)
- Feng J, "Downregulation of Bmal1 expression in celiac ganglia protects against hepatic ischemia-reperfusion injury", Biomolecules, 13, pp.713~ (2023)
- Liu L, "Melatonin ameliorates cerebral ischemia-reperfusion injury in diabetic mice by enhancing autophagy via the SIRT1-BMAL1 pathway", FASEB J, 35, pp.e22040~ (2021)
- Yu S, "m6A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injury", Hepatology (2023)[DOI]
- Dong J, "SRY is a key mediator of sexual dimorphism in hepatic ischemia", reperfusion injury, 2022, pp.276, 345~356
- Czigany Z, "Ischemia-reperfusion injury in marginal liver grafts and the role of hypothermic machine perfusion : molecular mechanisms and clinical implications", J Clin Med, 9, pp.846~ (2020)
- Palladini G, "Obeticholic acid reduces kidney matrix metalloproteinase activation following partial hepatic ischemia", reperfusion injury in rats, 2022, pp.15, 524~
- Li S, "Dietary inorganic nitrate protects hepatic ischemia-reperfusion injury through NRF2-mediated antioxidative stress", Front Pharmacol, 12, pp.634115~ (2021)
- Hou W, "The protective effect of panax notoginseng mixture on hepatic ischemia", reperfusion injury in mice via regulating NR3C2, SRC, and GAPDH, 2021, pp.12, 756259~
- Wang X, "Susceptibility of rat steatotic liver to ischemiareperfusion is treatable with liver-selective matrix metalloproteinase inhibition", Hepatology, 72, pp.1771~1785 (2020)
- Zhang P, "Endothelial Notch activation promotes neutrophil transmigration via downregulating endomucin to aggravate hepatic ischemia", reperfusion injury, 2020, pp.63, 375~387
- Hirao H, "Neutrophil CEACAM1 determines susceptibility to NETosis by regulating the S1PR2", S1PR3 axis in liver transplantation, 2023, pp.133, e162940~
